Возраст домена | 9 лет |
Дата окончания | Истек срок регистрации |
ИКС | 10 |
Страниц в Google | 20000 |
Страниц в Яндексе | 10 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 2850691 |
Alexa Country | ![]() |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Biotech Capital - Home
healthcare, pharma, biotech, biotech capital, conferences, small cap, mid cap, NASDAQ, NYSE, penny stocks, biotech news, biotech index, equity, investing.
BioTech Capital leads the world in connecting pharmaceutical and med-tech companies with the global investor community
UTF-8
173.96 КБ
1 842
14 493 симв.
12 248 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
20 | 9 |
0 | 1 | ![]() | |
![]() ![]() |
10 | 8 |
0 | 2126 | ![]() | |
![]() ![]() |
9 | 5 |
0 | 216553 | ![]() | |
![]() ![]() |
9 | 4 |
10 | 20228 | ![]() | |
![]() ![]() |
9 | 8 |
0 | 563 | ![]() | |
![]() ![]() |
9 | 5 |
0 | 9175 | ![]() | |
![]() ![]() |
8 | 2 |
10 | 145998 | ![]() | |
![]() ![]() |
8 | 5 |
20 | 134421 | ![]() | |
![]() |
8 | 5 |
0 | 159042 | ![]() | |
![]() ![]() |
5 | 7 |
0 | 16741 | ![]() | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Внешние ссылки главной страницы ( 15 ) | |
proactiveinvestors.co.uk | Pro UK |
proactiveinvestors.com | Pro NA |
proactiveinvestors.com.au | Pro AU |
fullertreacymoney.com | <img> |
stocktube.com | <img> |
oilcapital.com/ | Oil Capital |
miningcapital.com/ | Mining Capital |
tech-capital.com/ | Tech Capital |
capitalnetwork.com/ | CN |
twitter.com/bio_tech1 | - |
youtube.com/user/ProactiveInvestors | - |
linkedin.com/company/proactive-investors | - |
smartcoresearch.com/ | <img> |
facebook.com/ProactiveInvestors | - |
twitter.com/proactive_uk | - |
Внутренние ссылки главной страницы ( 99 ) | |
# | - |
/page/55/About%20us | About us |
/conferences | Conferences |
/companies/sponsors | All Featured |
/companies | All Companies |
/companies/sponsors/united_kingdom | UK Featured |
/companies/sponsors/north_america | North America Featured |
/companies/sponsors/australia | Australia Featured |
/archives/articles | Articles |
/archives/bigPicture | VIEW ALL |
/archives/in_brief | Newswires |
/archives/video | Videos |
/page/68/Contact%20Us | Contact Us |
/research | Capital Network Research |
/rss/rss.xml | - |
/members/signup | Sign up |
/members/login | Login |
/archives/sector/pharma-biotech/news/34/Local | View More |
/companies/news/216584/biocept-prices-82m-registered-direct-... | Biocept prices $8.2M registered direct offering to institutional investors |
/companies/news/216583/immunoprecise-says-modiquest-managing... | Fri - ImmunoPrecise says ModiQuest managing director leaving to take CEO role |
/companies/news/216510/achieve-life-sciences-shares-continue... | Fri - Achieve Life Sciences shares continue to soar on the back of 4Q earnings results |
/companies/news/216511/regenerative-medicine-company-organog... | Fri - Regenerative medicine company Organogenesis rallies after announcing $100M credit facility |
/companies/news/216528/optibiotix-extends-lpldl-supply-agree... | Fri - OptiBiotix extends LPLDL supply agreement with German probiotics firm HLH |
/companies/news/216501/shield-therapeutics-says-european-pat... | Thu - Shield Therapeutics says European Patent Office decides in company’s favour in relation to a Feracru patent |
/companies/news/216421/neovasc-announces-secondary-offering-... | Thu - Neovasc announces secondary offering, aims to raise more than US$4M |
/companies/news/216479/summit-therapeutics-shows-off-potenti... | Thu - Summit Therapeutics shows off potential of Discuva platform at Berlin conference |
/companies/news/216474/widecells-issues-115mln-shares-as-inv... | Thu - WideCells issues 115mln shares as investors converts £115,000 worth of bonds |
/companies/news/216450/netscientific-unaware-of-any-reason-b... | Thu - NetScientific unaware of any reason behind recent share price jump |
/companies/news/216451/synairgen-to-include-more-severe-copd... | Thu - Synairgen to include more severe COPD patients in phase II SNG001 study |
/companies/news/216400/namaste-technologies-completes-acquis... | Wed - Namaste Technologies completes acquisition of 49% of established cannabis delivery group Pineapple Express |
/companies/news/216399/biocept-rises-after-announcing-expans... | Wed - Biocept rises after announcing expansion of pathology partnership platform |
/companies/news/216388/syncona-shares-fall-as-wellcome-trust... | Wed - Syncona shares fall as Wellcome Trust says will sell a small percentage of its shareholding in firm |
/companies/news/216368/hikma-pharma-falls-as-it-narrowly-mis... | Wed - Hikma Pharma falls as it narrowly misses forecasts with 2018 results |
/companies/news/216309/callitas-health-promotes-joshua-mauri... | Tue - Callitas Health promotes Joshua Maurice to sales VP |
/companies/news/216185/arecor-appoints-ex-ixico-cfo-susan-lo... | March 11 2019 - Arecor appoints ex-IXICO CFO Susan Lowther as its new finance chief |
/companies/news/216157/silence-therapeutics-gearing-up-for-e... | March 11 2019 - Silence Therapeutics gearing up for “exciting” year |
/companies/news/216118/stellar-biotechnologies-in-reverse-me... | March 08 2019 - Stellar Biotechnologies in reverse merger with Edesa Biotech; shares shoot higher |
/companies/news/216057/paradigm-biopharmaceuticals-director-... | March 08 2019 - Paradigm Biopharmaceuticals director shows confidence with on-market share purchase |
/archives/sector/pharma-biotech/articles/34/Local | VIEW ALL ARTICLES |
/companies/news/216582/soleno-stock-price-triples-as-safety-... | Soleno stock price triples as safety board gives go-ahead to continue Prader-Willi trial |
/companies/news/216571/scynexis-says-phase-3-program-underwa... | SCYNEXIS says Phase 3 program underway for treatment of acute yeast infection |
/companies/news/216499/leanlife-to-start-testing-samples-at-... | LeanLife to start testing samples at Ecovatec’s manufacturing facility in British Columbia |
/companies/news/216482/volitionrx-strengthens-balance-sheet-... | VolitionRx strengthens balance sheet in 2018 as Nu.Q blood test notches further advances in cancer-detection trials |
/companies/news/216447/immupharma-continues-to-engage-with-p... | ImmuPharma continues to engage with potential corporate partners for Lupuzor, its late-stage treatment for Lupus |
/companies/news/216427/imugene-doses-milestone-first-patient... | Imugene doses milestone first patient for cancer vaccine trial |
biotech-capital.com/LON:NSCI/Netscientific-PLC/ | Netscientific PLC |
biotech-capital.com/LON:FUM/Futura-Medical-PLC/ | Futura Medical PLC |
biotech-capital.com/LON:WDC/WideCells-Group/ | WideCells Group |
biotech-capital.com/LON:PYC/Physiomics-Plc/ | Physiomics Plc |
biotech-capital.com/LON:ETX/e-Therapeutics-plc/ | e-Therapeutics plc |
biotech-capital.com/LON:VAL/ValiRx-Plc/ | ValiRx Plc |
/teams/details/348/Dennis%20Fitzgerald | Dennis Fitzgerald, |
/teams/details/119/Giles%20Gwinnett | Giles Gwinnett, |
/teams/details/320/Katie%20Lewis | Katie Lewis, |
/teams/details/235/Tom%20Howard | Tom Howard, |
/teams/details/317/Uttara%20Choudhury | Uttara Choudhury, |
/teams/details/263/Jon%20Hopkins%20 | Jon Hopkins , |
/archives/sector/pharma-biotech/stock-tubes/34/Local | VIEW ALL VIDEOS |
/companies/stocktube/12628/admedus-ceo-in-new-york-to-update... | Admedus CEO in New York to update on recent key milestones |
/companies/stocktube/12623/hemispherx-biopharma-updates-on-c... | Hemispherx Biopharma updates on current trials, gears up to begin 5 more |
/companies/stocktube/12620/medexus-pharmaceuticals-will-begi... | Medexus Pharmaceuticals will begin selling Treosulfan in Canada, and will... |
/companies/stocktube/12615/imugene-doses-first-patient-in-ph... | Imugene doses first patient in phase-two study of cancer vaccine |
/companies/stocktube/12599/volitionrx-well-funded-as-it-adva... | VolitionRx well funded as it advances development of its novel cancer tests |
/companies/stocktube/12589/aequus-pharmaceuticals-acquires-c... | Aequus Pharmaceuticals acquires Canadian rights to therapies for Dry Eye |
/companies/stocktube/12575/zynerba-pharmaceuticals-well-fund... | Zynerba Pharmaceuticals well-funded for its CBD clinical trials into 2021 |
/companies/stocktube/12574/namaste-technologies-addresses-re... | Namaste Technologies addresses recent challenges as they look to grow in the... |
/companies/stocktube/12568/q-biomed-licenses-significant-bio... | Q BioMed licenses significant biomarker to diagnose glaucoma |
/companies/stocktube/12562/ilera-healthcare-deal-is--one-pie... | Ilera Healthcare deal is 'one piece of the puzzle' for Zelda Therapeutics in... |
/companies/stocktube/12556/medlab-clinical-chief-updates-on-... | Medlab Clinical chief updates on progress with NanaBis and NRG Biotic |
/companies/stocktube/12550/cytodyn-files-for-fast-track-desi... | CytoDyn files for fast-track designation for leronlimab in breast cancer... |
/archives/conference-videos | VIEW ALL CONFERENCE VIDEOS |
/companies/stocktube/7012/itus-corporation-ceo-robert-berman... | ITUS Corporation CEO Robert Berman presents at Biotech Capital Conference |
/companies/stocktube/7011/sphere-medical-s-richard-wright-pr... | Sphere Medical's Richard Wright Presents to Investors at the Biotech Capital... |
/companies/stocktube/7010/tim-mitchell-updates-investors-on-... | Tim Mitchell updates investors on progress at Sareum Holdings at the Biotech... |
/companies/stocktube/7008/tissue-regenix-ceo-antony-odell-pr... | Tissue Regenix CEO Antony Odell Presents at Biotech Capital Conference |
/companies/stocktube/7007/mimedx-s-mark-landy-presents-at-th... | MiMedx's Mark Landy Presents at the Biotech Capital Conference |
/companies/stocktube/7006/realm-therapeutics-ceo-alex-martin... | Realm Therapeutics CEO Alex Martin presents to investors at the Biotech... |
/companies/news/216323/orgenesis-leads-the-charge-at-an-exci... | Orgenesis leads the charge at an exciting time for cell therapy |
/companies/news/216124/hemispherx-biopharma-takes-cancer-war... | Hemispherx Biopharma takes cancer war to new stage with drug Ampligen |
/companies/news/215945/leanlife-health-rides-the-omega-3-fat... | LeanLife Health rides the Omega-3 fatty acid fitness boom |
/companies/news/215750/cytodyn-presses-forward-with-hiv-trea... | CytoDyn presses forward with HIV treatment after Phase 3 |
/companies/news/215256/humanigen-pins-hopes-on-monoclonal-an... | Humanigen pins hopes on monoclonal antibody treatment of cancer therapy's side effects |
/companies/news/215352/arev-brands-throws-spotlight-on-canna... | AREV Brands throws spotlight on cannabis and CBD from seed to the shelf |
/companies/news/215447/namaste-technologies-looks-to-become-... | Namaste Technologies looks to become the ‘Amazon of cannabis’ with its integrated, intelligent cannabis experience |
/companies/news/215247/immupharma-continues-to-build-data-pa... | ImmuPharma continues to build data package for flagship lupus treatment |
/companies/news/215244/faron-pharmaceuticals-makes-good-star... | Faron Pharmaceuticals makes good start to Clevegen immunotherapy trial |
/companies/research/110648/shield-therapeutics-plc-feraccru-... | Shield Therapeutics PLC - Feraccru: a potential game changer in the... |
/companies/research/110626/avacta-group-maximising-affimer-s... | Avacta Group - Maximising Affimer's potential across therapeutics and... |
/companies/research/110624/judges-scientific-plc-2018-interi... | Judges Scientific PLC - 2018 Interim Results |
/companies/research/110619/legendary-investments-hidden-valu... | Legendary Investments - Hidden value potential |
/companies/research/110616/avacta-group-exciting-partnership... | Avacta Group - Exciting partnership with Bach BioSciences |
/companies/research/110600/avacta-group-rapid-progress-of-im... | Avacta Group - Rapid Progress of Immuno-oncology Programs |
/page/55/About us | Our Company |
/pages/terms | Term & Conditions |
/contact_us | Contact us |
/members/index | Newsletter |
/pages/sitemap | Sitemap |
/pages/73/workForUs | Work for us |
/members/recover | Click here for recovery |
Domain Name: biotech-capital.com
Registry Domain ID: 1941862809_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Update Date: 2015-06-25T08:34:12Z
Creation Date: 2015-06-25T08:34:12Z
Registrar Registration Expiration Date: 2017-06-25T08:34:12Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: +1.4806242505
Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited
Domain Status: clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited
Domain Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
Registry Registrant ID: Not Available From Registry
Registrant Name: Craig Ribton
Registrant Organization:
Registrant Street: 44a Shelbourne Road
Registrant City: BOURNEMOUTH
Registrant State/Province: Dorset
Registrant Postal Code: BH88RA
Registrant Country: UK
Registrant Phone: +44.1202770386
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: craig@proactiveinvestors.com
Registry Admin ID: Not Available From Registry
Admin Name: Craig Ribton
Admin Organization:
Admin Street: 44a Shelbourne Road
Admin City: BOURNEMOUTH
Admin State/Province: Dorset
Admin Postal Code: BH88RA
Admin Country: UK
Admin Phone: +44.1202770386
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: craig@proactiveinvestors.com
Registry Tech ID: Not Available From Registry
Tech Name: Craig Ribton
Tech Organization:
Tech Street: 44a Shelbourne Road
Tech City: BOURNEMOUTH
Tech State/Province: Dorset
Tech Postal Code: BH88RA
Tech Country: UK
Tech Phone: +44.1202770386
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: craig@proactiveinvestors.com
Name Server: KANYE.NS.CLOUDFLARE.COM
Name Server: KRISTIN.NS.CLOUDFLARE.COM
>>> Last update of WHOIS database: 2017-02-03T22:00:00Z <<<
For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en
User-agent: *
Disallow:
Австралия - Сидней - 203.15.147.66
Australian Stock Exchange Limited
Australian Stock Exchange
HTTP/1.1 200 OK
Date: Mon, 18 Mar 2019 05:19:00 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Set-Cookie: __cfduid=d5471cd54d3e6073fff9520c0e84908a01552886337; expires=Tue, 17-Mar-20 05:18:57 GMT; path=/; domain=.biotech-capital.com; HttpOnly; Secure
X-Powered-By: PHP/5.3.29
Set-Cookie: CAKEPHP=62kgbod729i3uifknb745750j7; expires=Mon, 18-Mar-2019 17:18:59 GMT; path=/; secure; HttpOnly
Vary: Accept-Encoding
Set-Cookie: SRVID=B|XI8qR|XI8qR; path=/
Cache-control: private
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Server: cloudflare
CF-RAY: 4b94bfbba8cdc18b-IAD
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"